Agno Pharma
Agno Pharma, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various regions. Founded in [year], the company has established itself as a leader in the development and distribution of innovative healthcare solutions. Agno Pharma focuses on a diverse range of therapeutic areas, including [specific areas if known], and is recognised for its commitment to quality and efficacy. The company’s core products and services are distinguished by their unique formulations and adherence to stringent regulatory standards, ensuring optimal patient outcomes. Over the years, Agno Pharma has achieved significant milestones, solidifying its market position and reputation for excellence. With a dedication to advancing healthcare, Agno Pharma continues to make strides in the pharmaceutical landscape, contributing to improved health and well-being globally.
DitchCarbon Score
How does Agno Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Agno Pharma's score of 18 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Agno Pharma's reported carbon emissions
Agno Pharma, headquartered in the United States, is committed to addressing climate change through significant emissions reduction initiatives. Although specific carbon emissions data for recent years is not available, the company has set a long-term science-based target to achieve net-zero greenhouse gas emissions across its entire value chain by no later than 2050. This commitment encompasses all scopes of emissions, indicating a comprehensive approach to sustainability. As part of its climate strategy, Agno Pharma is actively working towards establishing measurable reduction targets, demonstrating its dedication to environmental responsibility within the pharmaceuticals, biotechnology, and life sciences sector. The company’s commitment to net-zero emissions reflects an understanding of the urgent need for action against climate change and aligns with industry standards for sustainability. While specific numerical targets or achievements have not been disclosed, Agno Pharma's pledge to reach net-zero emissions by 2050 positions it as a proactive player in the fight against climate change, contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Agno Pharma is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
